OCN Symptom Management

Question 1

A patient reports a pain level of 8/10 on opioid therapy. Which principle guides reassessment timing after a dose change?

Accepted Answer

Reassess within 1 hour for IV opioids and 2 hours for oral opioids

Answer

Reassess only at the next scheduled visit

Answer

Reassess after 24 hours for all routes

Answer

Reassess only if the patient calls the nurse

Question 2

Which antiemetic class is considered first-line for chemotherapy-induced nausea and vomiting (CINV)?

Accepted Answer

5-HT3 receptor antagonists (e.g., ondansetron)

Answer

Dopamine antagonists (e.g., metoclopramide)

Answer

Corticosteroids alone

Answer

Benzodiazepines alone

Question 3

Mucositis in oncology patients most commonly occurs in which setting?

Accepted Answer

After head and neck radiation or high-dose chemotherapy

Answer

During maintenance hormone therapy

Answer

After targeted therapy with erlotinib

Answer

During anti-CD20 immunotherapy

Question 4

What is the first-line treatment for opioid-induced constipation in oncology patients?

Accepted Answer

Stimulant laxative (e.g., senna) with or without a stool softener

Answer

Increased dietary fiber alone

Answer

Increased water intake alone

Answer

Enemas as needed only

Question 5

Cancer-related fatigue (CRF) differs from normal fatigue in which key way?

Accepted Answer

CRF is not relieved by rest or sleep

Answer

CRF resolves after one full night of sleep

Answer

CRF is caused only by anemia

Answer

CRF only occurs during chemotherapy

Question 6

Which non-pharmacological intervention has the strongest evidence for reducing cancer-related fatigue?

Accepted Answer

Moderate aerobic exercise

Answer

Complete bed rest

Answer

High-dose vitamins

Answer

Massage therapy alone